Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.

van Gils L, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Brecker S, Bapat V, Modine T, Soliman OI, Nersesov A, Allocco D, Falk V, Van Mieghem NM.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):119-128. doi: 10.1016/j.jcin.2017.10.016.

PMID:
29348006
2.

Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.

Zahn R, Werner N, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, Sack S, Abdel-Wahab M, Hoffmann E, Zeymer U, Schneider S; German Transcatheter Aortic Valve Interventions—Registry investigators.

Heart. 2017 Dec;103(24):1970-1976. doi: 10.1136/heartjnl-2016-311004. Epub 2017 Jul 6.

PMID:
28684438
3.

Erratum to: Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators.

Clin Res Cardiol. 2017 Oct;106(10):849. doi: 10.1007/s00392-017-1124-z. No abstract available.

PMID:
28676951
4.

Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.

Falk V, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Linke A, Ince H, Wenaweser P, Allocco DJ, Dawkins KD, Van Mieghem NM.

Eur Heart J. 2017 Dec 1;38(45):3359-3366. doi: 10.1093/eurheartj/ehx297.

PMID:
28651336
5.

Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study.

Gerckens U, Tamburino C, Bleiziffer S, Bosmans J, Wenaweser P, Brecker S, Guo J, Linke A.

Eur Heart J. 2017 Sep 21;38(36):2729-2738. doi: 10.1093/eurheartj/ehx295.

6.

Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators.

Clin Res Cardiol. 2017 Oct;106(10):784-795. doi: 10.1007/s00392-017-1120-3. Epub 2017 May 8. Erratum in: Clin Res Cardiol. 2017 Jul 4;:.

PMID:
28484830
7.

Nose cone entrapment after transcatheter aortic valve implantation of a CoreValve self-expandable bioprosthesis.

Pyxaras SA, Pizzulli L, Gerckens U.

J Cardiovasc Med (Hagerstown). 2016 Dec;17 Suppl 2:e183-e184. doi: 10.2459/JCM.0000000000000090.

PMID:
28482354
8.

Cardio-anesthesiology considerations for the trans-catheter aortic valve implantation (TAVI) procedure.

Melidi E, Latsios G, Toutouzas K, Vavouranakis M, Tolios I, Gouliami M, Gerckens U, Tousoulis D.

Hellenic J Cardiol. 2016 Nov - Dec;57(6):401-406. doi: 10.1016/j.hjc.2016.10.001. Epub 2016 Oct 6. Review.

9.

Incidence and Clinical Impact of Stroke Complicating Transcatheter Aortic Valve Implantation: Results From the German TAVI Registry.

Werner N, Zeymer U, Schneider S, Bauer T, Gerckens U, Linke A, Hamm C, Sievert H, Eggebrecht H, Zahn R; German Transcatheter Aortic Valve Interventions-Registry Investigators.

Catheter Cardiovasc Interv. 2016 Oct;88(4):644-653. doi: 10.1002/ccd.26612. Epub 2016 Jun 3.

PMID:
27258944
10.

Four-year experience with the CoreValve transcatheter heart valve.

Kovac J, Schuler G, Gerckens U, Müller R, Serruys PW, Bonan R, Labinaz M, den Heijer P, Mullen M, Tymchak W, Grube E.

EuroIntervention. 2016 Oct 10;12(8):e1039-e1046. doi: 10.4244/EIJY15M10_10.

11.

Impact of Anesthesia Type on Outcomes of Transcatheter Aortic Valve Implantation (from the Multicenter ADVANCE Study).

Brecker SJ, Bleiziffer S, Bosmans J, Gerckens U, Tamburino C, Wenaweser P, Linke A; ADVANCE Study Investigators.

Am J Cardiol. 2016 Apr 15;117(8):1332-8. doi: 10.1016/j.amjcard.2016.01.027. Epub 2016 Jan 28.

PMID:
26892451
12.

Three-Year Outcomes of Transcatheter Aortic Valve Implantation in Patients With Varying Levels of Surgical Risk (from the CoreValve ADVANCE Study).

Barbanti M, Schiltgen M, Verdoliva S, Bosmans J, Bleiziffer S, Gerckens U, Wenaweser P, Brecker S, Gulino S, Tamburino C, Linke A; ADVANCE Study Investigators.

Am J Cardiol. 2016 Mar 1;117(5):820-7. doi: 10.1016/j.amjcard.2015.11.066. Epub 2015 Dec 13.

PMID:
26762727
13.

One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience.

Toutouzas K, Latsios G, Stathogiannis K, Drakopoulou M, Synetos A, Sanidas E, Mastrokostopoulos A, Trantalis G, Kaitozis O, Lazaros G, Yuecel S, Gerckens U, Grube E, Tousoulis D.

Int J Cardiol. 2016 Jan 1;202:631-5. doi: 10.1016/j.ijcard.2015.09.075. Epub 2015 Sep 25.

PMID:
26451789
14.

The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients.

Bosmans J, Bleiziffer S, Gerckens U, Wenaweser P, Brecker S, Tamburino C, Linke A; ADVANCE Study Investigators.

J Am Coll Cardiol. 2015 Jul 21;66(3):209-217. doi: 10.1016/j.jacc.2015.05.025.

15.

Comparison of outcomes of patients with left ventricular ejection fractions ≤30% versus ≥30% having transcatheter aortic valve implantation (from the German Transcatheter Aortic Valve Interventions Registry).

Schaefer U, Zahn R, Abdel-Wahab M, Gerckens U, Linke A, Schneider S, Eggebrecht H, Sievert H, Figulla HR, Senges J, Kuck KH; German TAVI Registry.

Am J Cardiol. 2015 Mar 1;115(5):656-63. doi: 10.1016/j.amjcard.2014.12.019. Epub 2014 Dec 18.

PMID:
25613664
16.

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study.

Brecker S, Mealing S, Padhiar A, Eaton J, Sculpher M, Busca R, Bosmans J, Gerckens UJ, Wenaweser P, Tamburino C, Bleiziffer S, Piazza N, Moat N, Linke A.

Open Heart. 2014 Oct 23;1(1):e000155. doi: 10.1136/openhrt-2014-000155. eCollection 2014.

17.

Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry.

Eggebrecht H, Mehta RH, Haude M, Sack S, Mudra H, Hein R, Brachmann J, Gerckens U, Kuck KH, Zahn R, Sechtem U, Richardt G, Schneider S, Senges J.

EuroIntervention. 2014 Sep;10(5):602-8. doi: 10.4244/EIJV10I5A105.

18.

Innate immune inflammatory response in the acutely ischemic myocardium.

Deftereos S, Angelidis C, Bouras G, Raisakis K, Gerckens U, Cleman MW, Giannopoulos G.

Med Chem. 2014;10(7):653-62. Review.

PMID:
25102201
19.

Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.

Abdel-Wahab M, Zahn R, Gerckens U, Linke A, Sievert H, Schäfer U, Kahlert P, Hambrecht R, Sack S, Hoffmann E, Senges J, Schneider S, Richardt G; German TAVI Registry Investigators.

Heart. 2014 Aug;100(16):1250-6. doi: 10.1136/heartjnl-2013-305385. Epub 2014 Jun 3.

PMID:
24895354
20.

Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study.

Linke A, Wenaweser P, Gerckens U, Tamburino C, Bosmans J, Bleiziffer S, Blackman D, Schäfer U, Müller R, Sievert H, Søndergaard L, Klugmann S, Hoffmann R, Tchétché D, Colombo A, Legrand VM, Bedogni F, lePrince P, Schuler G, Mazzitelli D, Eftychiou C, Frerker C, Boekstegers P, Windecker S, Mohr FW, Woitek F, Lange R, Bauernschmitt R, Brecker S; ADVANCE study Investigators.

Eur Heart J. 2014 Oct 7;35(38):2672-84. doi: 10.1093/eurheartj/ehu162. Epub 2014 Mar 28.

Supplemental Content

Loading ...
Support Center